GQA Consulting: Pharmaceutical and Biotechnology Quality Systems Consultants

Quality Systems Services

Quality Systems Services

Skip to content
  • Welcome to G.Q.A.
  • Quality Systems Services
    • Quality Systems Development
    • Training Programs
    • Quality Systems Auditing
    • Quality Assurance / Quality Control for Virtual Companies
  • About
    • The Team
    • Affiliates
  • Resources
    • Industry Links
    • Terms & Definitions
  • News
  • Contact
  • Quality Systems Development
  • Training Programs
  • Quality Systems Auditing
  • Quality Assurance / Quality Control for Virtual Companies

Comments are closed.

  • Contact GQA

    • 1-303-459-2382
    • 1-866-216-2815
    • info@gqaconsulting.com
  • Industry Definitions

    FDA Form 483

    A listing of observations of objectionable conditions and practices, pursuant to Section 704(b) of the Federal Food, Drug, and Cosmetic Act, to assist firms in complying with the Acts and regulations enforced by the Food and Drug Administration. This listing is presented to the highest management official available upon completing an inspection and before leaving the premises.
    »More terms
  • News & Events

    • FDA Emphasizing Supplier Controls
    • Pharmaceutical Compounding
    • 21 CFR 111 Compliance
    • Welcome to G.Q.A.
    • Quality Systems Services
    • About
    • Resources
    • News
    • Contact
    • Login
  • Copyright 2000 - 2013 Global Quality Alliance, LLC - All rights reserved.
Web Development by DD9™